Get the Stockscreener App
102.99
1.96%
-2.06
After Hours:
102.99
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $102.99, with a volume of 988.29K.
It is down -1.96% in the last 24 hours and up +2.18% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$105.05
Open:
$105.21
24h Volume:
988.29K
Relative Volume:
0.72
Market Cap:
$11.68B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
43.83
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
+6.45%
1M Performance:
+2.18%
6M Performance:
+4.34%
1Y Performance:
-11.67%
1-Day Range:
$102.34
$106.00
1-Week Range:
$96.58
$106.39
52-Week Range:
$81.36
$128.28
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
102.99 | 11.91B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY) - Yahoo Finance
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
What to expect from Revvity’s Q4 2025 earnings report - MSN
What to Expect From Revvity’s Q4 2025 Earnings Report - inkl
Do Options Traders Know Something About Revvity (RVTY) Stock We Don't? - MSN
Revvity Earnings Notes - Trefis
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ - MSN
Trading Systems Reacting to (RVTY) Volatility - Stock Traders Daily
Allspring Global Investments Holdings LLC Has $70.79 Million Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3 - Insider Monkey
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Revvity Inc.: Quiet Re?Rating Story in a Volatile Diagnostics Market - AD HOC NEWS
Revvity, Inc. Faces Valuation Shift Amid Declining Sales and Rising Costs - Markets Mojo
Can Revvity Inc. stock deliver strong annual returnsCandlestick Trading Patterns & Affordable Trading Growth - bollywoodhelpline.com
Revvity Inc. Stock Finds Its Footing as Investors Weigh Diagnostics Demand and AI Ambitions - AD HOC NEWS
Revvity Inc. Stock Price Live, Charts & News - The Economic Times
Revvity, Inc.'s (NYSE:RVTY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛
Revvity advances AI-driven scientific discovery with Signals Xynthetica - MSN
Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
(RVTY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Did Revvity’s New AI Discovery Platform (RVTY) Quietly Redefine Its Innovation Moat? - simplywall.st
Revvity introduces AI-augmented design platform for molecular and materials discovery - BioSpectrum India
Aug Patterns: How Revvity Inc stock reacts to global recession fearsJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn
Is Revvity Inc. stock a defensive play in 2025Global Markets & Stepwise Trade Signal Implementation - Улправда
How cyclical is Revvity Inc. stock compared to rivalsJuly 2025 Price Swings & Comprehensive Market Scan Reports - DonanımHaber
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica - TradingView — Track All Markets
Will Revvity Inc. stock reach all time highs in 2025Weekly Trade Report & Expert Verified Stock Movement Alerts - DonanımHaber
Raymond James reiterates Outperform rating on Revvity stock after site visit - Investing.com Nigeria
Raymond James reiterates Outperform rating on Revvity stock after site visit By Investing.com - Investing.com India
What consensus target says about Revvity Inc. stockRate Cut & AI Optimized Trade Strategies - DonanımHaber
Why Revvity Inc. stock could outperform in 2025Weekly Profit Analysis & Precise Buy Zone Tips - DonanımHaber
Will Revvity Inc. stock benefit from automationJuly 2025 Closing Moves & Technical Buy Zone Confirmations - Улправда
Is Revvity Inc. stock a buy on dipsWeekly Trading Summary & Daily Price Action Insights - Улправда
What analyst consensus says on Revvity Inc. stockInsider Selling & Proven Capital Preservation Tips - Улправда
Revvity (BSP:R1VT34) EV-to-OCF : 22.14 (As of Dec. 18, 2025) - GuruFocus
Will Revvity Inc. stock see PE expansionMarket Activity Summary & High Conviction Buy Zone Picks - ulpravda.ru
Revvity to Present at J.P. Morgan Healthcare Conference - Business Wire
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet? - simplywall.st
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE: RVTY) officer disposes 25 shares for RSU tax withholding - Stock Titan
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design - Indian Pharma Post
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity to launch AI models-as-a-service for scientific discovery - Investing.com Nigeria
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials D - PharmiWeb.com
Revvity Introduces New AI Service for Molecular, Materials Design - marketscreener.com
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.56%
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):